Everus Construction Group, Inc.

ECG
About the company

Everus Construction Group, Inc. provides contracting services in the United States. It operates through two segments, Electrical & Mechanical and Transmission & Distribution. The Electrical & Mechanical segment provides construction and maintenance services of electrical and communication wiring, and infrastructure; fire suppression systems; and renewables infrastructure and mechanical piping services in public and private sectors.

Country: United StatesPrice: $85.25Market Cap: $4.4B

Investment snapshot

41%positive consensus
Scored 1d ago

Positive

6

BUY / PASS

Neutral / negative

6 / 4

NEUTRAL / FAIL

Median fair value

$44.62

-47.7% vs price

Models with upside

1 / 17

Positive margin of safety

Strongest signal

6 of 8 pass — Graham and Piotroski object

Key risk

Split decision: 6 NEUTRAL · 4 FAIL · 4 PASS · 2 BUY

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILPASSFAILBUY · Rank #244 (Top 7.9%)PASSNEUTRALPASSFAILBUYFAILNEUTRALPASSNEUTRALBUYNEUTRALNEUTRALNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/A
Margin of Safety-157.3%N/A-25.1%-155.9%N/A-80.4%-193.4%N/A+35.9%-91.1%-168.1%-91.1%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

TTM ended 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-25

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-25

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-25

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-25

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-06

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-06

Score computed: 2026-11-14

Where It Passes

  • Efficiency75% pass✓ 8✗ 3▾

    6 of 8 pass — Graham and Piotroski object

    Current Ratio1.53
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)28.1%
    ✓Buffett> 10%
    ROIC - WACC+18.1%
    ✓BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)64.4%
    ✓Greenblatt> 25%
    Current Ratio Change YoY1.79 -> 1.76
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY2.21x -> 2.17x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities1.53
    ✓Dreman> 1.5
    Return on Invested Capital21.0%
    ✓Munger> 15%
    ROIC (high and growing)FY2023: ROIC=33.5%; FY2024: ROIC=20.9%; FY2025: ROIC=22.9%
    ✓AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC22.9% (RR=100% x ROIC=22.9%)
    ✓AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)3/3 years above 12% (latest 22.9%)
    ✓SleepROIC > 12% in a majority of years
  • Verdicts64% pass✓ 7✗ 4▾

    Split decision: 6 NEUTRAL · 4 FAIL · 4 PASS · 2 BUY

    Overall verdict
    ✗GrahamFAIL (2/9)✓BuffettPASS (4/9)✗LynchFAIL (3/7)✓GreenblattRank #244✓PiotroskiPASS (F-Score 5)•DremanNEUTRAL (7/11)✓MungerPASS (2/4)✗PabraiFAIL (1/3)✓AkreBUY (5/6)✗MarksFAIL (2/5)•AckmanNEUTRAL (6/9)✓TempletonPASS (4/8)•SleepNEUTRAL (4/6)✓AsnessBUY (Rank #418/2370 (Top 17.6%))•NeffNEUTRAL (4/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked)
  • Growth63% pass✓ 8✗ 5▾

    5 of 8 pass — Graham, Lynch and Sleep object

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)1.25
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR17.3%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 34.7% vs Rev: 33.5%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$2.45 (2022) -> $3.95 (2025)
    ✓DremanPositive over recent years
    EPS CAGR17.3% CAGR over 3 years
    ✓Dreman> 5% annualized
    Positive Net Income Frequency4/4 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth5.7%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency3/3 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR17.3% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 11.3% -> 12.1%, operating margin 6.7% -> 7.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR17.3% over 3 years
    ✓Neff7%-20% annualized

Where It Falls Short

  • Valuation8% pass✓ 4✗ 24▾

    12 of 13 flag ECG's valuation — Graham, Lynch, Greenblatt +9 more

    Net income / market capitalization+6.65%; #1254/6340 (top 19.8%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Price / 3-yr avg EPS27.1x
    ✗Graham<= 15x
    Price-to-Book Ratio6.9x
    ✗Graham<= 1.5x
    P/E x P/B186.80
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)1.25
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value8.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=8.1%, ROC=64.4%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS21.6x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)27.7x
    ✗Dreman< 8x
    Price / Book Value per Share6.9x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=21.6x
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=21.6x, FCF Yield=2.1%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=21.6x, P/B=6.9x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value-80.4% (IV=$47.25 vs Price=$85.25)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share48.3x
    ✗Ackman<= 25
    Price vs. Trailing Low230% of trailing low ($37.09)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Positive book equity / market capitalization+0.1986; #4197/6449 (top 65.1%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS21.6x
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E0.80
    ✓Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share8.94x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+64.7%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+1.0714; #1687/5247 (top 32.2%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+5.45%; #1493/4519 (top 33.0%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-34.58%; #4608/6202 (top 74.3%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Valuation models11% pass✓ 1✗ 8▾

    Models split on ECG at $85.25 — fair values range $29.06–$133.01

    Graham fair value$33.13
    ✗Graham-157.3% margin vs $85.25
    Lynch fair value$68.17
    ✗Lynch-25.1% margin vs $85.25
    Greenblatt fair value$33.31
    ✗Greenblatt-155.9% margin vs $85.25
    Dreman fair value$47.25
    ✗Dreman-80.4% margin vs $85.25
    Munger fair value$29.06
    ✗Munger-193.4% margin vs $85.25
    Akre fair value$133.01
    ✓Akre+35.9% margin vs $85.25
    Marks fair value$44.62
    ✗Marks-91.1% margin vs $85.25
    Ackman fair value$31.80
    ✗Ackman-168.1% margin vs $85.25
    Templeton fair value$44.62
    ✗Templeton-91.1% margin vs $85.25
  • Profitability25% pass✓ 18✗ 17▾

    12 of 16 flag ECG's profitability — Graham, Buffett, Lynch +9 more

    Net income / market capitalization+6.65%; #1254/6340 (top 19.8%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive EPS (10 years)4/5 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)4/5 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)32.3%
    ✓Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)7.1% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)1.25
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR17.3%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE33.5%
    ✓Lynch> 15%
    EBIT / Enterprise Value8.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=8.1%, ROC=64.4%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets11.67%
    ✓PiotroskiROA > 0
    ROA Change YoY11.13% -> 11.67% (delta: +0.54%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=9.07%, ROA=11.67%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY11.9% -> 12.1%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue8.0%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity33.5%
    ✓Dreman> 12%
    Margin of SafetyP/E=21.6x, P/B=6.9x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity32.2% (3-yr avg)
    ✓AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value-80.4% (IV=$47.25 vs Price=$85.25)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency4/4 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue8.2%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity33.5%
    ✓Ackman>= 15%
    5-Year EPS CAGR17.3% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend6.7% (2023) -> 7.1% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 11.3% -> 12.1%, operating margin 6.7% -> 7.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Gross profit / total assets+23.51%; #1818/3702 (top 49.1%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+33.48%; #385/5226 (top 7.4%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0080; #687/5884 (top 11.7%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR17.3% over 3 years
    ✓Neff7%-20% annualized
    Positive Diluted-EPS Years
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Cash Flow40% pass✓ 6✗ 6▾

    6 of 10 flag ECG's cash flow — Buffett, Piotroski, Dreman +3 more

    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    FCF Positive and Growing$237.4M
    ✓LynchPositive and growing
    Operating Cash Flow$156.8M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=9.07%, ROA=11.67%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)27.7x
    ✗Dreman< 8x
    P/E or FCF YieldP/E=21.6x, FCF Yield=2.1%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive3/4 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap5.5%
    ✓Ackman>= 4%
    Price / FCF per Share48.3x
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency3/4 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$237.4M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+5.45%; #1493/4519 (top 33.0%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage50% pass✓ 8✗ 7▾

    6 of 12 pass — Buffett, Lynch, Munger +3 more object

    LT Debt vs Net Current AssetsLT Debt $542.5M vs NCA $612.3M
    ✓GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.66, IC: 18.7x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.66
    ✗Lynch< 0.33
    Cash - Long-term Debt$-297.7M
    ✗LynchPositive preferred
    LT Debt / Total Assets Change21.78% -> 15.42%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.53
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.66
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.66
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=13.4x, D/EBITDA=N/A (D&A unavailable)
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.66
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.6551; #2755/4210 (top 65.4%)
    ✗AsnessTop 30% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Construction
SIC Sector: Building Construction
Size: Mid Cap($4.4B)
Revenue: $3.7B+31.5% YoY
Net Income: $201.8M+40.7% YoY

Financial Snapshot

Operating Margin7.1%
Return on Equity32.0%
Debt / Equity0.45
Current Ratio1.76
EPS (Diluted)$3.95+40.6% 1y
Shares Retired−0.0% / −0.1% 2y

Shareholder Return

Fiscal 2025

Issued 0.0% of shares last year, 0.1% issued over two.

Buybacks
—
Dividends
$0

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY23
9.8% = 10.0% + −0.2%
FY24
4.5% = 4.5% + −0.0%
FY25
40.6% = 40.7% + −0.1%
Earnings Fewer shares More shares

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, capex, dividends paid.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-25
FY 2024
Sources
  • 10-K · 2025-02-28
FY 2023
Sources
  • 10-K · 2025-02-28
FY 2022
Sources
  • 10-K · 2025-02-28
FY 2021
Sources
  • 10-K · 2025-02-28
Market Cap$4.4Bcurrent------$4.5Best.$3.5Best.$2.6Best.----
Revenue$4.7B↑33%$1.4B↑40%$1.2B↑34%$1.0B↑25%$3.7B↑31%$2.8B$2.9B↑6%$2.7B--
Operating Income$380.7M↑57%$122.4M↑69%$111.8M↑54%$77.7M↑52%$264.8M↑39%$189.9M$190.5M↑16%$164.6M--
Net Income$289.4M↑60%$91.9M↑61%$83.9M↑59%$58.3M↑59%$201.8M↑41%$143.4M↑5%$137.2M↑10%$124.8M--
EPS (Diluted)--$1.79↑61%$1.64↑59%$1.14↑58%$3.95↑41%$2.81↑4%$2.69↑10%$2.45--
Gross Margin13.6%↑13%14.8%↑18%14.9%↑14%12.6%↑13%12.1%↑2%11.9%↑6%11.3%↑10%10.2%—
Operating Margin8.2%↑18%8.8%↑21%9.1%↑15%7.5%↑21%7.1%↑6%6.7%6.7%↑9%6.1%—
ROE33.5%↑6%———32.0%↓6%33.9%↑11%30.6%↓6%32.6%—
Total Debt$566.3M↑99%$566.3M↑99%$274.5M↓5%$278.0M↓5%$281.5M↓5%$295.6M$0----
Shareholders' Equity$864.5M↑51%$864.5M↑51%$773.2M↑50%$686.9M↑49%$629.8M↑49%$422.6M↓6%$448.9M↑17%$382.2M↑5%$362.9M
Current Ratio1.53↓13%1.53↓13%1.59↓10%1.77↓1%1.76↓1%1.79↓3%1.85——
Debt / Equity0.66↑32%0.66↑32%0.36↓37%0.40↓36%0.45↓36%0.700.00——
Operating Cash Flow$315.5M↑67%$70.5M↓7%$53.1M↑110%$143.7M↑1916%$156.8M↓4%$163.4M↓5%$171.3M↑772%-$25.5M--
Free Cash Flow$237.4M↑78%$52.7M↓20%$33.0M↑169%$128.2M↑1224%$90.0M↓22%$115.1M↓15%$135.7M↑321%-$61.3M--

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Construction

ECG vs Peers — Financial Grading

Revenue$3.7BBottom 25%
Net Income$201.8MBottom 25%
ROE32.0%Top 25%
D/E0.45Median
Op. Margin7.1%Bottom 25%
Curr. Ratio1.76Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
HITACHI LTDHTHIY$137.0B$30.83——————1/90/92/70/3F-Score 73/11
QUANTA SERVICES, INC.PWR$90.7B$602.01$28.5B$1.0B11.5%0.675.7%1.141/91/93/71/3F-Score 53/11
HORTON D R INC /DE/DHI$39.5B$145.55$34.3B$3.6B14.8%0.25——4/92/94/70/3F-Score 44/11
EMCOR Group, Inc.EME$28.9B$659.36$17.0B$1.3B34.6%0.0010.1%1.223/96/96/71/3F-Score 76/11
PULTEGROUP INC/MI/PHM$23.4B$127.01$17.3B$2.2B17.1%———3/92/95/71/3F-Score 35/11
JACOBS SOLUTIONS INC.J$18.7B$158.23$12.0B$289.3M7.9%0.617.2%1.303/91/92/71/3F-Score 71/11
MASTEC INCMTZ$14.7B$182.78$14.3B$399.0M12.2%0.72—1.321/91/92/71/3F-Score 83/11
Toll Brothers, Inc.TOL$13.6B$147.85$11.0B$1.3B16.3%0.1115.7%—3/94/95/71/3F-Score 47/11